Berlin, Germany

Jörg Willuda

USPTO Granted Patents = 5 

Average Co-Inventor Count = 3.7

ph-index = 4

Forward Citations = 60(Granted Patents)


Company Filing History:


Years Active: 2006-2012

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Jörg Willuda: Innovator in Chimeric Immunoglobulin Stabilization

Introduction

Jörg Willuda is a distinguished inventor based in Berlin, Germany, known for his impactful contributions to the field of immunology. With three patents to his name, he focuses on advancing methods for the stabilization of chimeric immunoglobulins and immunoglobulin fragments, demonstrating a commitment to innovation in biotechnology.

Latest Patents

Willuda's latest patents include a pivotal invention titled "Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments," as well as a related development involving a "stabilized anti-EGP-2 scFv fragment." Both inventions relate to enhancing the stability and efficacy of chimeric immunoglobulins and immunoglobulin fragments, which have significant implications for therapeutic applications in cancer treatment and other diseases. His work in this area contributes to the growing field of targeted therapy, offering new avenues for medical advancements.

Career Highlights

Currently associated with the University of Zurich, Jörg Willuda has carved out a reputation as a key player in biotechnological research, particularly in immunotherapy. His innovative approaches to chimeric proteins have garnered recognition within the scientific community and have paved the way for further developments in the field.

Collaborations

Willuda collaborates with esteemed colleagues, including Andreas Plückthun and Annemarie Honegger. Their combined expertise enhances the research efforts at the University of Zurich, fostering an environment of innovation and collaboration that drives forward significant advancements in biotechnology.

Conclusion

Jörg Willuda stands out as a remarkable inventor in the realm of chimeric immunoglobulin stabilization, making strides toward revolutionary breakthroughs in immunotherapy. His dedication to research and development, alongside his collaborations, positions him as a noteworthy figure in the landscape of contemporary biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…